Sara Ramponi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIMS To establish feasibility of the combination of Erlotinib and concurrent chemoradiation in pre-treated patients with locally advanced or metastatic NSCLC. MATERIALS AND METHODS Data regarding 60 consecutive patients with NSCLC previously treated with chemotherapy alone were prospectically collected. All patients started Erlotinib concurrently with(More)
  • 1